Skip to main content

Advertisement

Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

Fig. 1

a Oncoprint showing the distribution of the investigated biomarkers (YAP, TAZ, CTNNB1, APC, FBXW7) together with the cases with at least one mutations in Wnt pathway components (integrated pathway analysis). b MutationMapper illustrating the entire set of detected mutations (and their nature) represented on the linear proteins

Back to article page